1940 results
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... Action: Inhibits DPP ... GLP-I receptor agonist ... EricsMedicalLectures/featured #DPP4
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
GLP-1 Receptor Agonists ... • DPP4i / Gliptins
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
- PPAR gamma agonist ... AGENTS • GLP-1 agonists ... (Adlyxin) • DPP ... by inhibiting DPP
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
GLP-1 receptor agonists ... events TZDs DPP
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Metformin + DPP4 ... dapagliflozin) Dpp4
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... linagliptin) 5 mg DPP4 ... lower dose of a DPP4 ... /ambcarerx #DPP4
Classification of Adrenergic Receptor Agonists (sympathomymetics)

#Adrenergic #Receptor #Agonists #sympathomymetics #Classification #Pharmacology
Adrenergic Receptor Agonists ... Adrenergic #Receptor #Agonists
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
short-acting β2-agonists ... long-acting β2-agonists ... StepUp #Treatment #Algorithm
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Daily GLP-1 Agonists ... very similar to DPP4s ... #GLP1 #Agonists
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
mu-opioid receptor agonist ... displacing full agonists ... As a partial agonist ... However, full agonists ... As a partial agonist